CVE-2023-36146
A Stored Cross-Site Scripting (XSS) vulnerability was found in Multilaser RE 170 using firmware 2...
A Stored Cross-Site Scripting (XSS) vulnerability was found in Multilaser RE 170 using firmware 2.2.6733.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- Required
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
5.4
A Stored Cross-Site Scripting (XSS) vulnerability was found in Multilaser RE 170 using firmware 2.2.6733.
- Record
CVE-2023-36146- CVSS 3.1
- 5.4 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
A Stored Cross-Site Scripting (XSS) vulnerability was found in Multilaser RE 170 using firmware 2.2.6733.
- Record
CVE-2023-36146- Updated
- 2026-11-02
EUVDEUVD-2023-40125 No score
A Stored Cross-Site Scripting (XSS) vulnerability was found in Multilaser RE 170 using firmware 2.2.6733.
- Record
EUVD-2023-40125- Updated
- 2026-11-02
GitHub AdvisoriesGHSA-m263-35mj-mjp4
5.4
A Stored Cross-Site Scripting (XSS) vulnerability was found in Multilaser RE 170 using firmware 2...
A Stored Cross-Site Scripting (XSS) vulnerability was found in Multilaser RE 170 using firmware 2.2.6733.
- Record
GHSA-m263-35mj-mjp4- CVSS 3.1
- 5.4 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
Public exploits
Links only. Every CVE stores no exploit code.
| Source | Link | Date |
|---|---|---|
| PoC in GitHub | leonardobg/CVE-2023-36146 | 2023-06-22 |
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD, PoC in GitHub |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2023-36146 is a medium vulnerability (CVSS 5.4) in Multilaser Re170, published June 30, 2023. Public exploit code exists. EPSS puts the chance of exploitation in the next 30 days at 0.47%, the 40th percentile. No source names a fixed version.